LogicBio Therapeutics Story

LOGCDelisted Stock  USD 2.07  0.00  0.00%   
About 56% of LogicBio Therapeutics' investor base is looking to short. The analysis of current outlook of investing in LogicBio Therapeutics suggests that many traders are alarmed regarding LogicBio Therapeutics' prospects. LogicBio Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in LogicBio Therapeutics. The current market sentiment, together with LogicBio Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use LogicBio Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
LogicBio Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of LogicBio daily returns and investor perception about the current price of LogicBio Therapeutics as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for LogicBio Therapeutics.

LogicBio Therapeutics Latest Timeline

LogicBio Therapeutics is listed for 2.07. About 49.0% of the company shares are owned by institutional investors. The book value of LogicBio Therapeutics was now reported as 0.48. The company recorded a loss per share of 1.12. LogicBio Therapeutics had not issued any dividends in recent years.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the LogicBio Therapeutics information on this page should be used as a complementary analysis to other LogicBio Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Consideration for investing in LogicBio Stock

If you are still planning to invest in LogicBio Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LogicBio Therapeutics' history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Global Correlations
Find global opportunities by holding instruments from different markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules